Precigen Inc (PGEN)

6.92
+0.52(+8.12%)
After Hours
6.92
0.00(0.00%)
- Real-time Data
  • Volume:
    1,403,311
  • Bid/Ask:
    6.80/7.00
  • Day's Range:
    6.11 - 6.93

PGEN Overview

Prev. Close
6.4
Day's Range
6.11 - 6.93
Revenue
103.17M
Open
6.4
52 wk Range
2.14 - 11.1
EPS
-0.56
Volume
1,403,311
Market Cap
1.43B
Dividend (Yield)
N/A (N/A)
Average Vol. (3m)
1,284,759
P/E Ratio
-
Beta
2.36
1-Year Change
166.15%
Shares Outstanding
206,414,135
Next Earnings Date
Aug 12, 2021
What is your sentiment on Precigen Inc?
or
Market is currently closed. Voting is open during market hours.

Precigen Inc News

Precigen Inc Analysis

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesStrong BuyStrong BuyBuySellStrong Sell
Technical IndicatorsStrong BuyStrong BuyStrong BuyStrong SellBuy
SummaryStrong BuyStrong BuyStrong BuyStrong SellNeutral

Precigen Inc Company Profile

Precigen Inc Company Profile

Employees
563

Precigen, Inc., formerly Intrexon Corporation, forms collaborations to create biologically-based products and processes using synthetic biology. The Company's domestic operations are in California, Florida, Maryland, and Virginia, and its primary international operations are in Belgium and Hungary. The Company designs, builds and regulates gene programs, which are deoxyribonucleic acid (DNA) sequences that consist of genetic components. The Company's synthetic biology capabilities include the ability to control the amount, location and modification of biological molecules to control the function and output of living cells and optimize for desired results at an industrial scale. The Company's technologies include UltraVector gene design and fabrication platform, and its associated library of modular DNA components; Cell Systems Informatics; RheoSwitch inducible gene switch; AttSite Recombinases; Protein Engineering; Laser-Enabled Analysis and Processing (LEAP), and ActoBiotics platform.

Read More
  • 20% bump today with FDA orphan drug designation.
    0
    • PGEN $8.20 -2.84% @ Close (Earnings)
      0
      • PGEN $8.27 +0.61% @ Close! Sideways since exit, but holding tough in a weaker NASDQ market.
        0
        • PGEN $8.33 @ Friday Close!
          0
          • PGEN $8.30 @ 12:52 PM ET ... Stopped on 1/2 bull. Flat of PGEN
            0
            • PGEN $8.80 +1.15% ... raising bull stop to $8.30 from $7.30. @ 02:30 PM ET.
              0
              • PGEN $8.10 @ Friday close!
                0
                • This week's trade at $7.50 is a triple bottom sell signal, which negates the previously noted bull vertical count. My stop loss is firm $7.35. The trade at $7.50 could be a "bear trap" should we get a reversal back up to $10.00, which would get the shares back on a buy signal. Bullish support trend @ $6.50.
                  0
              • PGEN .... brought to my attention by Guns and Glory in VX chat 1/26/2021.  Bull vertical count to $19.50 is upper end of retracement.  Recent Secondary Offering at $7.50.  Secondary probably shorted by underwriters as a hedge, but they are covered.  However, sell side firms may be short, undhedged, belief that secondary is diluted.  #11 on NASDAQ short interest and good environment for a short squeeze. https://invst.ly/tluey
                0
                • Very bullish from 2nd June, when a fund bought a lot of shares.
                  0
                  • buy or sell?
                    0
                    • Buy. Its up today 20%
                      0
                  • have a look in Curetis NV I think the price will go up to 4.50euros.
                    0
                    • dollars
                      0
                    • nice bro
                      0
                  • Simmons, that post is nearly a year old and no longer valid
                    0
                    • curetis is a good investment Is my opinion.
                      0
                  • Dear Mr. Khan, are you sure ?
                    0
                    • It actually has beeen over 6 since he posted that :D
                      0
                  • GOING to 6 this time
                    1
                    Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All derived (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
                    Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.